Cargando…

Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells

The cancer stem cell (CSC) hypothesis postulates that cancer originates from the malignant transformation of stem/progenitor cells and is considered to apply to many cancers, including liver cancer. Identification that CSCs are responsible for drug resistance, metastasis, and secondary tumor appeara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wuputra, Kenly, Lin, Chang-Shen, Tsai, Ming-Ho, Ku, Chia-Chen, Lin, Wen-Hsin, Yang, Ya-Han, Kuo, Kung-Kai, Yokoyama, Kazunari K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725927/ https://www.ncbi.nlm.nih.gov/pubmed/29259714 http://dx.doi.org/10.1186/s41232-017-0041-x

Ejemplares similares

Potential application of cell reprogramming techniques for cancer research
por: Saito, Shigeo, et al.
Publicado: (2018)

Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
por: Wuputra, Kenly, et al.
Publicado: (2020)

Translational models of 3-D organoids and cancer stem cells in gastric cancer research
por: Wuputra, Kenly, et al.
Publicado: (2021)

Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
por: Saito, Shigeo, et al.
Publicado: (2022)

Stem Cell Biomarkers and Tumorigenesis in Gastric Cancer
por: Wuputra, Kenly, et al.
Publicado: (2022)

Redox control in the pathophysiology of influenza virus infection
por: Chen, Ker-Kong, et al.
Publicado: (2020)

FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells
por: Wuputra, Kenly, et al.
Publicado: (2022)

Generation of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research
por: Ku, Chia-Chen, et al.
Publicado: (2022)

Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer
por: Kuo, Kung-Kai, et al.
Publicado: (2021)

Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy Model
por: Wu, Deng-Chyang, et al.
Publicado: (2023)

Control of Oxidative Stress and Generation of Induced Pluripotent Stem Cell-like Cells by Jun Dimerization Protein 2
por: Chiou, Shyh-Shin, et al.
Publicado: (2013)

Jdp2 is a spatiotemporal transcriptional activator of the AhR via the Nrf2 gene battery
por: Wuputra, Kenly, et al.
Publicado: (2023)

Bovine Induced Pluripotent Stem Cells Are More Resistant to Apoptosis than Testicular Cells in Response to Mono-(2-ethylhexyl) Phthalate
por: Lin, Ying-Chu, et al.
Publicado: (2014)

Jun dimerization protein 2 controls hypoxia‐induced replicative senescence via both the p16(Ink4a)‐pRb and Arf‐p53 pathways
por: Nakade, Koji, et al.
Publicado: (2017)

Jdp2-deficient granule cell progenitors in the cerebellum are resistant to ROS-mediated apoptosis through xCT/Slc7a11 activation
por: Ku, Chia-Chen, et al.
Publicado: (2020)

Author Correction: Jdp2-deficient granule cell progenitors in the cerebellum are resistant to ROS-mediated apoptosis through xCT/Slc7a11 activation
por: Ku, Chia-Chen, et al.
Publicado: (2020)

Dimethyl sulfoxide stimulates the AhR-Jdp2 axis to control ROS accumulation in mouse embryonic fibroblasts
por: Wuputra, Kenly, et al.
Publicado: (2021)

Independent Signaling of Hepatoma Derived Growth Factor and Tumor Necrosis Factor-Alpha in Human Gastric Cancer Organoids Infected by Helicobacter pylori
por: Wuputra, Kenly, et al.
Publicado: (2023)

Deletion of Jdp2 enhances Slc7a11 expression in Atoh-1 positive cerebellum granule cell progenitors in vivo
por: Ku, Chia-Chen, et al.
Publicado: (2021)

Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer
por: Wang, Sophie S.W., et al.
Publicado: (2016)

Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells
por: Lin, Ying-Chu, et al.
Publicado: (2014)

Breast Cancer with Increased Drug Resistance, Invasion Ability, and Cancer Stem Cell Properties through Metabolism Reprogramming
por: Chong, Kian-Hwee, et al.
Publicado: (2022)

Environmental-stress-induced Chromatin Regulation and its Heritability
por: Fang, Lei, et al.
Publicado: (2014)

Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
por: Abd, Genevieve M., et al.
Publicado: (2023)

Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy
por: Chen, Yi-Lun, et al.
Publicado: (2022)

Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts
por: Xia, Xiaohuan, et al.
Publicado: (2020)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer
por: Tsai, Wen-Chen, et al.
Publicado: (2018)

Conditional reprogramming: next generation cell culture
por: Wu, Xiaoxiao, et al.
Publicado: (2020)

Generation and Application of Directly Reprogrammed Endothelial Cells
por: Jung, Cholomi, et al.
Publicado: (2022)

Epigenetic Landscapes Explain Partially Reprogrammed Cells and Identify Key Reprogramming Genes
por: Lang, Alex H., et al.
Publicado: (2014)

MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin(+) cells
por: Chiou, Shih-Hwa, et al.
Publicado: (2011)

Differential expression profiles of the transcriptome in bone marrow-derived cells in lung cancer revealed by next generation sequencing and bioinformatics
por: Chang, Wei-An, et al.
Publicado: (2019)

Reprogramming Cancer Cells to Antigen-presenting Cells
por: Ferreira, Alexandra G., et al.
Publicado: (2023)

Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation
por: Shen, Yao-An, et al.
Publicado: (2013)

Reprogramming the human cancer cell nucleus
por: Frenster, John, et al.
Publicado: (2010)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer
por: Prieto, Javier, et al.
Publicado: (2017)

A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation
por: Li, Zhonghan, et al.
Publicado: (2012)

Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
por: Chu, Pei-Yi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e26t5gk2irn7cuv46cnr9f33kd